CCL2 and gastric cancer: Our study found that 50 μM of DIM (corresponding to IC50 in gastric cancer cell lines) had almost no lethal effect on GC-MSCs, but could activate the NF-κB signaling pathway and increase the expression of CCL2, IL-6, IL-8, TGF-β.